Epidemiology from Literature | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 9.790 | 20100301, Scala E
| 1.10 - Any allergy symptom, Diagnosed | 2011 | Italy | IgE | 786 | 28.600 | 20110902, Gadermaier G
| 4.1.1 - Heterologous Source Sensitized (Symptoms) | 2008 | Spain | IgE | 785 | 12.990 | 20081010, Barber D
| 4.1.5 - Heterologous Source Sensitized (IgE) | 2011 | Italy | IgE | 431 | 69.140 | 20111123, Bernardi ML
| 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.000 | 20120528, Patelis A
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2010 | Italy / Austria / Switzerland / Netherlands | IgE | 237 | 19.830 | 20101118, Bublin M
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 233 | 43.800 | 20120726, Flores E
| 1.8 - Fruit Allergy | 2012 | Spain | IgE | 212 | 68.000 | 20120912, Palacin A
| 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Netherlands | IgE | 211 | 5.200 | 20140331, Rockmann H
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2010 | Italy / Austria / Switzerland / Netherlands | IgE | 198 | 8.590 | 20101118, Bublin M
| 1.4 - Respiratory Symptoms, Diagnosed | 2013 | Spain | IgE | 187 | 12.800 | 20131016, Feliu A
| 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2013 | Spain | IgE | 175 | 4.500 | 20130807, Letran A
| 4.1.5 - Heterologous Source Sensitized (IgE) | 2010 | Sweden | IgE | 150 | 0.000 | 20100212, Asarnoj A
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2011 | Italy | IgE | 148 | 70.270 | 20110810, Pastorello EA
| 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 2.860 | 20130111, Ott H
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2014 | Spain | IgE | 130 | 46.150 | 20140401, Armentia A
| 1.4 - Respiratory Symptoms, Diagnosed | 2012 | France | IgE | 129 | 7.000 | 20121204, Caimmi D
| 1.9 - Pollen Allergy | 2012 | Spain | IgE | 117 | 15.000 | 20120912, Palacin A
| 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 5.900 | 20130912, Lacerda Araujo LM
| 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2011 | China | IgE | 100 | 3.000 | 20111214, Zheng YW
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 7.070 | 20110223, De Knop KJ
| 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 1.040 | 20120528, Patelis A
| 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 15.110 | 20101214, Gadisseur R
| 3.1.1 - Source Sensitized (SPT) | 2012 | Spain | IgE | 79 | 89.870 | 20121016, Javaloyes G
| 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 2.600 | 20131020, van Rhijn BD
| 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2003 | Spain | IgE | 76 | 61.800 | 20031017, Fernandez-Rivas M
| 1.4 - Respiratory Symptoms, Diagnosed | 2011 | Spain | IgE | 68 | 13.200 | 20110509, Rodriguez D
| 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 2012 | Spain | IgE | 68 | 36.800 | 20120726, Pedrosa M
| 1.11 - Esophagitis, Diagnosed | 2014 | Spain | IgE | 67 | 19.400 | 20140625, Armentia A
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Spain | IgE | 57 | 96.490 | 20130319, Boyano-Martinez T
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | China | IgE | 56 | 82.140 | 20120903, Gao ZS
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 55 | 45.500 | 20120726, Pedrosa M
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Austria | IgE | 54 | 48.150 | 20090416, Gaier S
| 1.1 - Asymptomatic | 2014 | Spain | IgE | 50 | 4.000 | 20140625, Armentia A
| 1.9 - Pollen Allergy | 2014 | Spain | IgE | 50 | 6.000 | 20140625, Armentia A
| 3.2.1 - Source Sensitized (IgE) | 2013 | China | IgE | 49 | 49.000 | 20130624, Ma S
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2002 | Spain | SPT | 47 | 91.500 | 2002, Garcia-Selles FJ
| 5.2.1 - Source Exposed (Symptoms, SPT) | 2007 | Spain | IgE | 44 | 88.600 | 20070123, Lauer I
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2013 | Netherlands | IgE | 43 | 25.580 | 20130429, Aalberse JA
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2010 | Spain | IgE | 43 | 88.370 | 20100618, Hartz C
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Netherlands | IgE | 42 | 21.430 | 20120905, Le TM
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2007 | Spain | IgE | 40 | 42.500 | 20070822, Palacin A
| 3.2.1 - Source Sensitized (IgE) | 2013 | China | IgE | 38 | 55.300 | 20130624, Ma S
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2013 | China | IgE | 38 | 55.300 | 20130624, Ma S
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 8.100 | 20090826, Ebo DG
| 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 8.570 | 20130605, Simon D
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | Italy | SPT | 33 | 78.780 | 20120930, Tuppo L
| 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2008 | Spain | SPT | 31 | 100.000 | 20081216, Armentia A
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2009 | Portugal | IgE | 30 | 96.660 | 20081126, Rodrigus-Alves R
| 4.1.3 - Heterologous Source Sensitized (SPT) | 2000 | Italy | IgE | 29 | 72.400 | 2000a, Asero R
| 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2005 | Spain | IgE | 27 | 37.000 | 20050614, Ahrazem O
| 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Spain | IgE | 26 | 34.610 | 20090526, Palacin A
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2009 | Italy | IgE | 26 | 96.150 | 20091204, Ciardiello MA
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2009 | Italy | SPT | 26 | 96.150 | 20091204, Ciardiello MA
| 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Democratic People's Republic of | IgE | 25 | 8.000 | 20140821, Choi JS
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2004 | Spain | IgE | 24 | 45.800 | 20040907, Lombardero M
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2007 | Spain | SPT | 24 | 45.000 | 20070822, Palacin A
| 5.2.1 - Source Exposed (Symptoms, SPT) | 2002 | Spain | SPT | 24 | 83.300 | 2002b, Carnes J
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2013 | China | IgE | 23 | 73.910 | 20130510, Ma S
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 4.550 | 20091121, Ebo DG
| 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 2013 | Netherlands | IgE | 22 | 36.360 | 20130429, Aalberse JA
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2013 | Belgium | IgE | 21 | 47.620 | 20130401, Ebo DG
| 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 5.000 | 20091005, Ott H
| 4.1.3 - Heterologous Source Sensitized (SPT) | 2002 | Spain | SPT | 20 | 30.000 | 2002, Garcia-Selles FJ
| 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 15.000 | 20091121, Ebo DG
| 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Japan | IgE | 17 | 35.290 | 20090330, Asakura K
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2006 | Spain | IgE | 17 | 94.100 | 20060401, Palacin A
| 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2002 | Italy | IgE (IB) | 17 | 100.000 | 2002b, Pastorello EA
| 1.6 - Anaphylaxis, Diagnosed | 2013 | Japan | IgE | 14 | 42.850 | 20131128, Inomata N
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2006 | Spain | SPT | 14 | 100.000 | 20060401, Palacin A
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Spain | IgE | 11 | 90.900 | 20110701, Tordesillas L
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2011 | Spain | IgE | 9 | 100.000 | 20110701, Tordesillas L
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Spain | IgE | 8 | 50.000 | 20091217, Palacin A
| 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Spain | IgE | 4 | 100.000 | 20110701, Tordesillas L
|
|